RxDoctor Payments Data
★ My doctorsLook up a doctor →

William Grass

Critical Care Medicine · Creve Coeur, MONPI 1407854383

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 293 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 60 manufacturers, the largest accounting for just 6.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,514 and has fallen 57.4% since, to $645 in 2025. Among critical care medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,869in general payments, 2019–2025

Across 293 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$353
  • Gilead$341
  • Johnson & Johnson$320
  • Daiichi Sankyo Inc.$271
  • Pfizer$269
  • Novartis$240
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$5,869100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation17$353
Gilead(2 entities)16$341
Johnson & Johnson17$320
Daiichi Sankyo Inc.15$271
Pfizer14$269
Novartis14$240
AstraZeneca(2 entities)12$240
Bristol Myers Squibb10$236
Merck8$184
Takeda Pharmaceuticals U.S.A., Inc.6$159
Genentech USA, Inc.8$155
Beigene USA, Inc.7$148
Bayer7$137
Eisai Inc.7$136
Sanofi8$132
Array Biopharma Inc7$130
Rigel Pharmaceuticals, Inc.5$129
Lilly USA, LLC4$123
Pharmaessentia USA Corporation5$113
Jazz Pharmaceuticals Inc.5$113
Amgen8$111
GSK4$109
Seagen Inc.7$105
AbbVie4$103
Astellas Pharma US Inc5$94
Kyowa Kirin, Inc.4$90
E.r. Squibb & Sons, L.L.C.4$87
Regeneron Healthcare Solutions, Inc.3$85
Epizyme, Inc.4$74
Servier Pharmaceuticals LLC3$67
Tersera Therapeutics LLC3$66
G1 Therapeutics, Inc.3$62
Pharmacyclics LLC, An Abbvie Company3$60
Springworks Therapeutics, Inc.2$59
Myovant Sciences Inc.4$56
AMAG Pharmaceuticals, Inc.3$49
Ipsen Biopharmaceuticals, Inc3$47
Stemline Therapeutics Inc.2$46
CTI Biopharma Corp.2$43
ADC Therapeutics America, Inc.2$43
Puma Biotechnology, Inc.3$43
Blueprint Medicines Corporation3$41
EMD Serono, Inc.2$37
Sumitomo Pharma America, Inc.2$30
Recordati_rare_diseases_inc.1$29
Foundation Medicine, Inc.1$29
Iovance Biotherapeutics, Inc.1$28
Myriad Genetic Laboratories, Inc.2$25
Biocon Biologics Inc1$25
Sobi, Inc1$22
Amneal Pharmaceuticals LLC1$21
Karyopharm Therapeutics Inc.1$18
Agios Pharmaceuticals, Inc.1$17
Genmab U.S., Inc.1$17
Dendreon Pharmaceuticals LLC1$17
Morphosys, US Inc.1$16
Alnylam Pharmaceuticals Inc.1$15
Clovis Oncology, Inc.1$15
Pharmacosmos Therapeutics Inc.1$14
Acrotech Biopharma Inc.1$13

How this compares

$5,869 in reported general payments places this provider in the 90th percentile of 208 critical care medicine providers in Missouri.

See all critical care medicine providers in Missouri →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin16$164
Prednisone21$128
Methylprednisolone13$94
Dexamethasone11$65
Ciprofloxacin Hcl11$42
Azithromycin11$35

Paid to pharmacies, not to this prescriber.

Other critical care medicine in Creve Coeur

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →